Skip to Content

Therapeutic Options for Patients with Primary Refractory or Early Relapsed DLBCL

In this MEDtalk, Manali Kamdar gives her perspectives on current therapeutic options for patients with primary refractory and early relapsed diffuse large B-cell lymphoma. What are the options for the large group of patients that cannot be offered stem cell transplants?

Manali Kamdar

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top